Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.41557360 |
2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.33840029 |
3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.18987679 |
4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.14653798 |
5 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.03637035 |
6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.93348936 |
7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.89595832 |
8 | negative T cell selection (GO:0043383) | 4.83721851 |
9 | negative thymic T cell selection (GO:0045060) | 4.76021556 |
10 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.68173558 |
11 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.62737493 |
12 | positive regulation of histone H3-K4 methylation (GO:0051571) | 4.55756777 |
13 | T cell migration (GO:0072678) | 4.49044831 |
14 | pre-miRNA processing (GO:0031054) | 4.31770077 |
15 | establishment of integrated proviral latency (GO:0075713) | 4.29089146 |
16 | maturation of SSU-rRNA (GO:0030490) | 4.25133740 |
17 | tolerance induction (GO:0002507) | 4.24429251 |
18 | viral transcription (GO:0019083) | 4.21167629 |
19 | regulation of gamma-delta T cell activation (GO:0046643) | 4.16795801 |
20 | DNA unwinding involved in DNA replication (GO:0006268) | 4.16421865 |
21 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.12867379 |
22 | translational termination (GO:0006415) | 4.12822196 |
23 | formation of translation preinitiation complex (GO:0001731) | 4.07732932 |
24 | positive thymic T cell selection (GO:0045059) | 4.05604387 |
25 | regulation of gene silencing by RNA (GO:0060966) | 4.03794205 |
26 | regulation of posttranscriptional gene silencing (GO:0060147) | 4.03794205 |
27 | regulation of gene silencing by miRNA (GO:0060964) | 4.03794205 |
28 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.97619832 |
29 | ribosomal small subunit assembly (GO:0000028) | 3.96216164 |
30 | thymic T cell selection (GO:0045061) | 3.95968817 |
31 | cotranslational protein targeting to membrane (GO:0006613) | 3.88334604 |
32 | protein targeting to ER (GO:0045047) | 3.86890230 |
33 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.86266080 |
34 | translational elongation (GO:0006414) | 3.86191338 |
35 | DNA deamination (GO:0045006) | 3.85521544 |
36 | ribosomal large subunit biogenesis (GO:0042273) | 3.82977608 |
37 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.81874534 |
38 | cytidine metabolic process (GO:0046087) | 3.77332330 |
39 | cytidine catabolic process (GO:0006216) | 3.77332330 |
40 | cytidine deamination (GO:0009972) | 3.77332330 |
41 | B cell receptor signaling pathway (GO:0050853) | 3.73690114 |
42 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.68003166 |
43 | protein complex localization (GO:0031503) | 3.67256390 |
44 | positive T cell selection (GO:0043368) | 3.66462413 |
45 | translational initiation (GO:0006413) | 3.64253846 |
46 | protein localization to endoplasmic reticulum (GO:0070972) | 3.63874420 |
47 | ribosome biogenesis (GO:0042254) | 3.63176322 |
48 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.62483545 |
49 | type I interferon signaling pathway (GO:0060337) | 3.62296314 |
50 | cellular response to type I interferon (GO:0071357) | 3.62296314 |
51 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.62254276 |
52 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.62001347 |
53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.61726460 |
54 | ribosomal small subunit biogenesis (GO:0042274) | 3.61393047 |
55 | immunoglobulin mediated immune response (GO:0016064) | 3.59137649 |
56 | response to type I interferon (GO:0034340) | 3.58806150 |
57 | positive regulation of B cell differentiation (GO:0045579) | 3.56162218 |
58 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.55840862 |
59 | T cell selection (GO:0045058) | 3.54536444 |
60 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.53833427 |
61 | regulation of regulatory T cell differentiation (GO:0045589) | 3.53651106 |
62 | nucleobase biosynthetic process (GO:0046112) | 3.52429024 |
63 | NIK/NF-kappaB signaling (GO:0038061) | 3.52218910 |
64 | establishment of viral latency (GO:0019043) | 3.51149089 |
65 | histone arginine methylation (GO:0034969) | 3.50280722 |
66 | regulation of B cell differentiation (GO:0045577) | 3.50231479 |
67 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.50220289 |
68 | pseudouridine synthesis (GO:0001522) | 3.49893487 |
69 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.49755789 |
70 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.49054355 |
71 | IMP biosynthetic process (GO:0006188) | 3.48017005 |
72 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.45319035 |
73 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.45319035 |
74 | B cell mediated immunity (GO:0019724) | 3.38696717 |
75 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.36951832 |
76 | viral life cycle (GO:0019058) | 3.36891712 |
77 | B cell homeostasis (GO:0001782) | 3.36561464 |
78 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.33410555 |
79 | negative regulation of T cell mediated immunity (GO:0002710) | 3.32058692 |
80 | spliceosomal snRNP assembly (GO:0000387) | 3.28873247 |
81 | negative regulation of histone methylation (GO:0031061) | 3.28671230 |
82 | cellular protein complex disassembly (GO:0043624) | 3.28317642 |
83 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.28265996 |
84 | COPI coating of Golgi vesicle (GO:0048205) | 3.27000092 |
85 | Golgi transport vesicle coating (GO:0048200) | 3.27000092 |
86 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.22469440 |
87 | regulation of cell killing (GO:0031341) | 3.21376043 |
88 | peptidyl-arginine N-methylation (GO:0035246) | 3.20801648 |
89 | peptidyl-arginine methylation (GO:0018216) | 3.20801648 |
90 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.20543450 |
91 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.19215819 |
92 | positive regulation of cell killing (GO:0031343) | 3.19039994 |
93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.18272246 |
94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.18227456 |
95 | positive regulation of interleukin-2 production (GO:0032743) | 3.17096377 |
96 | T cell costimulation (GO:0031295) | 3.15282716 |
97 | protein complex disassembly (GO:0043241) | 3.15268818 |
98 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.15060501 |
99 | ribosome assembly (GO:0042255) | 3.14719530 |
100 | rRNA processing (GO:0006364) | 3.13928327 |
101 | histone H2A acetylation (GO:0043968) | 3.13371360 |
102 | DNA replication initiation (GO:0006270) | 3.12784677 |
103 | positive regulation of defense response to virus by host (GO:0002230) | 3.12421831 |
104 | gonadal mesoderm development (GO:0007506) | 3.11760618 |
105 | lymphocyte costimulation (GO:0031294) | 3.10929223 |
106 | signal transduction involved in regulation of gene expression (GO:0023019) | 3.09490746 |
107 | mast cell activation (GO:0045576) | 3.08961059 |
108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07670968 |
109 | spliceosomal complex assembly (GO:0000245) | 3.07040491 |
110 | DNA strand elongation (GO:0022616) | 3.06640106 |
111 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05967573 |
112 | lymphocyte homeostasis (GO:0002260) | 3.05649305 |
113 | negative regulation of B cell proliferation (GO:0030889) | 3.05538305 |
114 | detection of bacterium (GO:0016045) | 3.05415312 |
115 | leukocyte aggregation (GO:0070486) | 3.04616668 |
116 | rRNA metabolic process (GO:0016072) | 3.04488971 |
117 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.03797529 |
118 | regulation of histone H3-K4 methylation (GO:0051569) | 3.02451831 |
119 | response to muramyl dipeptide (GO:0032495) | 3.01832667 |
120 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.01703226 |
121 | dendritic cell chemotaxis (GO:0002407) | 3.01614377 |
122 | defense response to protozoan (GO:0042832) | 3.01350649 |
123 | macromolecular complex disassembly (GO:0032984) | 3.01346403 |
124 | T cell receptor signaling pathway (GO:0050852) | 3.01340767 |
125 | negative regulation of RNA splicing (GO:0033119) | 3.00664426 |
126 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.99969723 |
127 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.99303753 |
128 | translation (GO:0006412) | 2.98545422 |
129 | positive regulation of granulocyte differentiation (GO:0030854) | 2.98240036 |
130 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.97547928 |
131 | purine nucleobase biosynthetic process (GO:0009113) | 2.95720877 |
132 | myeloid dendritic cell activation (GO:0001773) | 2.93890703 |
133 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.93702699 |
134 | regulation of translational fidelity (GO:0006450) | 2.93698172 |
135 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.93036047 |
136 | IMP metabolic process (GO:0046040) | 2.92377185 |
137 | positive regulation of T cell mediated immunity (GO:0002711) | 2.91396943 |
138 | viral mRNA export from host cell nucleus (GO:0046784) | 2.90549515 |
139 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.89587303 |
140 | regulation of protein heterodimerization activity (GO:0043497) | 2.88642916 |
141 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.88444738 |
142 | myeloid dendritic cell differentiation (GO:0043011) | 2.87983361 |
143 | negative regulation of viral genome replication (GO:0045071) | 2.87638046 |
144 | negative regulation of innate immune response (GO:0045824) | 2.87539577 |
145 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.87182406 |
146 | lymphocyte migration (GO:0072676) | 2.86699735 |
147 | regulation of T cell tolerance induction (GO:0002664) | 2.85101266 |
148 | regulation of antigen processing and presentation (GO:0002577) | 2.84748366 |
149 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.84721841 |
150 | detection of other organism (GO:0098543) | 2.84511166 |
151 | RNA splicing, via transesterification reactions (GO:0000375) | 2.83957231 |
152 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 2.83229741 |
153 | mRNA splicing, via spliceosome (GO:0000398) | 2.83229741 |
154 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.83091889 |
155 | Peyers patch development (GO:0048541) | 2.83091889 |
156 | regulation of T cell mediated immunity (GO:0002709) | 2.82796754 |
157 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.82118719 |
158 | T-helper cell differentiation (GO:0042093) | 2.82118719 |
159 | T cell homeostasis (GO:0043029) | 2.81206851 |
160 | response to interferon-beta (GO:0035456) | 2.81131796 |
161 | positive regulation of antigen processing and presentation (GO:0002579) | 2.80334054 |
162 | DNA strand renaturation (GO:0000733) | 2.79483355 |
163 | germinal center formation (GO:0002467) | 2.79405419 |
164 | mRNA catabolic process (GO:0006402) | 2.78884811 |
165 | RNA catabolic process (GO:0006401) | 2.78268401 |
166 | ribonucleoprotein complex assembly (GO:0022618) | 2.75919057 |
167 | mitotic nuclear envelope disassembly (GO:0007077) | 2.73354626 |
168 | termination of RNA polymerase II transcription (GO:0006369) | 2.73198758 |
169 | interferon-gamma production (GO:0032609) | 2.72761378 |
170 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.71853331 |
171 | cellular component biogenesis (GO:0044085) | 2.70698338 |
172 | ncRNA catabolic process (GO:0034661) | 2.70555910 |
173 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.67445001 |
174 | DNA duplex unwinding (GO:0032508) | 2.67008599 |
175 | nodal signaling pathway (GO:0038092) | 2.66891359 |
176 | ribonucleoprotein complex subunit organization (GO:0071826) | 2.66358708 |
177 | negative regulation of cell killing (GO:0031342) | 2.65412964 |
178 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.65412964 |
179 | DNA geometric change (GO:0032392) | 2.65014648 |
180 | termination of RNA polymerase III transcription (GO:0006386) | 2.63664914 |
181 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.63664914 |
182 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.63366094 |
183 | negative regulation of gene silencing (GO:0060969) | 2.62468678 |
184 | cellular response to interleukin-15 (GO:0071350) | 2.61960459 |
185 | regulation of histone H3-K9 methylation (GO:0051570) | 2.61725603 |
186 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.61495842 |
187 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.61495842 |
188 | tRNA aminoacylation for protein translation (GO:0006418) | 2.59579575 |
189 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.57898480 |
190 | response to interleukin-15 (GO:0070672) | 2.56909192 |
191 | membrane disassembly (GO:0030397) | 2.56873533 |
192 | nuclear envelope disassembly (GO:0051081) | 2.56873533 |
193 | negative regulation of mRNA processing (GO:0050686) | 2.56455203 |
194 | rRNA modification (GO:0000154) | 2.55586618 |
195 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.55567597 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.27057236 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.98257140 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.48971062 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.07968872 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.04017458 |
6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.94829054 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.56221306 |
8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.24180650 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.21956163 |
10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.15840905 |
11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.05392816 |
12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02101165 |
13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.97520503 |
14 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.91780408 |
15 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87577798 |
16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.86583616 |
17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.78244146 |
18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.73070662 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.69811201 |
20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.69279602 |
21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.68145039 |
22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.67162994 |
23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67047688 |
24 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.59019489 |
25 | * MYB_26560356_Chip-Seq_TH1_Human | 2.47502653 |
26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.39709119 |
27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.36579454 |
28 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.33475856 |
29 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28347317 |
30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.26101499 |
31 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.22351830 |
32 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.19301899 |
33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.18883575 |
34 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16672205 |
35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.10754667 |
36 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.09828202 |
37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.06609648 |
38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01601171 |
39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.01297634 |
40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.98740066 |
41 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.97213641 |
42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91261721 |
43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.90329276 |
44 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86082989 |
45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84348412 |
46 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.81628016 |
47 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79930565 |
48 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.78975308 |
49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.78935120 |
50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.77639883 |
51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.77286086 |
52 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76842805 |
53 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75685952 |
54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.75193829 |
55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72392058 |
56 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.71474239 |
57 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71045496 |
58 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.67366093 |
59 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.66648549 |
60 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.65810933 |
61 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65186117 |
62 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.63242672 |
63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58980167 |
64 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.58602881 |
65 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.58469487 |
66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.57376043 |
67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57298849 |
68 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57253775 |
69 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57109116 |
70 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.55846166 |
71 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52268821 |
72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.50761463 |
73 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50567248 |
74 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50540444 |
75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.50031095 |
76 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.49452612 |
77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.47495930 |
78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.43868256 |
79 | GATA3_26560356_Chip-Seq_TH2_Human | 1.43174677 |
80 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42599871 |
81 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.41387557 |
82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.41120484 |
83 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35654085 |
84 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.35316092 |
85 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34663143 |
86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33830482 |
87 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33264692 |
88 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33232572 |
89 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32697670 |
90 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.30801342 |
91 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30669114 |
92 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27130570 |
93 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.26077641 |
94 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.25805944 |
95 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.25312648 |
96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24541278 |
97 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.24420704 |
98 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23781071 |
99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.22476712 |
100 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.21727274 |
101 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20029259 |
102 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18867259 |
103 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.16315498 |
104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15173060 |
105 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14823971 |
106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14775966 |
107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14315118 |
108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.12471669 |
109 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.12453166 |
110 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12370663 |
111 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12249068 |
112 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11812471 |
113 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11764881 |
114 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09480368 |
115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08478396 |
116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.07726304 |
117 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07689618 |
118 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.07423652 |
119 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.07318808 |
120 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06826750 |
121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05474346 |
122 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03941240 |
123 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01652414 |
124 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01262961 |
125 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01254639 |
126 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99832907 |
127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99026544 |
128 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98964091 |
129 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98662224 |
130 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97931956 |
131 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96437400 |
132 | MAF_26560356_Chip-Seq_TH2_Human | 0.96133426 |
133 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96049516 |
134 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.95751232 |
135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94729346 |
136 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.93609597 |
137 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.93330700 |
138 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93176235 |
139 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.93055425 |
140 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92667851 |
141 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.92471358 |
142 | * MYB_26560356_Chip-Seq_TH2_Human | 0.92131965 |
143 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91952797 |
144 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.91123840 |
145 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89366194 |
146 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88603718 |
147 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.88542313 |
148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.87561540 |
149 | * MAF_26560356_Chip-Seq_TH1_Human | 0.87170522 |
150 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.85596007 |
151 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.85186936 |
152 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.84402591 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 4.25386340 |
2 | MP0008877_abnormal_DNA_methylation | 3.95953024 |
3 | MP0004957_abnormal_blastocyst_morpholog | 3.59618033 |
4 | MP0003436_decreased_susceptibility_to | 3.45526358 |
5 | MP0003890_abnormal_embryonic-extraembry | 3.27397761 |
6 | MP0003077_abnormal_cell_cycle | 2.91039221 |
7 | MP0003123_paternal_imprinting | 2.87455768 |
8 | MP0009785_altered_susceptibility_to | 2.71325729 |
9 | MP0010094_abnormal_chromosome_stability | 2.69888002 |
10 | MP0003724_increased_susceptibility_to | 2.68846697 |
11 | MP0005025_abnormal_response_to | 2.64938697 |
12 | MP0006292_abnormal_olfactory_placode | 2.64688495 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.60407063 |
14 | MP0004133_heterotaxia | 2.54514331 |
15 | MP0003303_peritoneal_inflammation | 2.52643965 |
16 | MP0003763_abnormal_thymus_physiology | 2.51449181 |
17 | MP0003111_abnormal_nucleus_morphology | 2.50652784 |
18 | MP0000013_abnormal_adipose_tissue | 2.29949685 |
19 | MP0005671_abnormal_response_to | 2.21886272 |
20 | MP0008058_abnormal_DNA_repair | 2.17998853 |
21 | MP0001730_embryonic_growth_arrest | 2.15365850 |
22 | MP0010155_abnormal_intestine_physiology | 2.13964221 |
23 | MP0002419_abnormal_innate_immunity | 2.12897724 |
24 | MP0002166_altered_tumor_susceptibility | 2.08316194 |
25 | MP0003183_abnormal_peptide_metabolism | 2.03592918 |
26 | MP0001873_stomach_inflammation | 2.03005295 |
27 | MP0008932_abnormal_embryonic_tissue | 2.00622757 |
28 | MP0006072_abnormal_retinal_apoptosis | 1.98471726 |
29 | MP0000678_abnormal_parathyroid_gland | 1.93670360 |
30 | MP0005645_abnormal_hypothalamus_physiol | 1.87651690 |
31 | MP0008057_abnormal_DNA_replication | 1.87495922 |
32 | MP0004947_skin_inflammation | 1.82655678 |
33 | MP0002693_abnormal_pancreas_physiology | 1.80961976 |
34 | MP0003119_abnormal_digestive_system | 1.80511017 |
35 | MP0000703_abnormal_thymus_morphology | 1.79896060 |
36 | MP0001845_abnormal_inflammatory_respons | 1.77637064 |
37 | MP0003121_genomic_imprinting | 1.74732466 |
38 | MP0003122_maternal_imprinting | 1.70496008 |
39 | MP0010352_gastrointestinal_tract_polyps | 1.68679525 |
40 | MP0001944_abnormal_pancreas_morphology | 1.67672640 |
41 | MP0008007_abnormal_cellular_replicative | 1.67461963 |
42 | MP0000465_gastrointestinal_hemorrhage | 1.64751339 |
43 | MP0002909_abnormal_adrenal_gland | 1.63247164 |
44 | MP0002006_tumorigenesis | 1.62299334 |
45 | * MP0002398_abnormal_bone_marrow | 1.60045974 |
46 | MP0000350_abnormal_cell_proliferation | 1.59278600 |
47 | MP0006082_CNS_inflammation | 1.58355990 |
48 | MP0002254_reproductive_system_inflammat | 1.55010422 |
49 | MP0001697_abnormal_embryo_size | 1.53349704 |
50 | MP0005464_abnormal_platelet_physiology | 1.52642500 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.48546406 |
52 | MP0003300_gastrointestinal_ulcer | 1.48179830 |
53 | MP0001533_abnormal_skeleton_physiology | 1.44743195 |
54 | MP0001853_heart_inflammation | 1.44600877 |
55 | MP0001800_abnormal_humoral_immune | 1.44139376 |
56 | MP0002722_abnormal_immune_system | 1.43097549 |
57 | MP0002084_abnormal_developmental_patter | 1.42486459 |
58 | MP0002138_abnormal_hepatobiliary_system | 1.39309348 |
59 | MP0000685_abnormal_immune_system | 1.38559173 |
60 | MP0000689_abnormal_spleen_morphology | 1.35413063 |
61 | MP0000313_abnormal_cell_death | 1.34777551 |
62 | MP0003283_abnormal_digestive_organ | 1.33787540 |
63 | MP0003866_abnormal_defecation | 1.31015158 |
64 | MP0002080_prenatal_lethality | 1.28090603 |
65 | MP0002163_abnormal_gland_morphology | 1.27264998 |
66 | MP0005380_embryogenesis_phenotype | 1.26996440 |
67 | MP0001672_abnormal_embryogenesis/_devel | 1.26996440 |
68 | MP0001529_abnormal_vocalization | 1.26818165 |
69 | MP0000003_abnormal_adipose_tissue | 1.26490482 |
70 | MP0002751_abnormal_autonomic_nervous | 1.25763391 |
71 | MP0002234_abnormal_pharynx_morphology | 1.25669848 |
72 | * MP0000716_abnormal_immune_system | 1.22290466 |
73 | MP0002085_abnormal_embryonic_tissue | 1.20904331 |
74 | MP0008469_abnormal_protein_level | 1.20547252 |
75 | MP0009672_abnormal_birth_weight | 1.20450396 |
76 | MP0002933_joint_inflammation | 1.17042992 |
77 | * MP0002723_abnormal_immune_serum | 1.16327205 |
78 | MP0002009_preneoplasia | 1.14141662 |
79 | MP0001790_abnormal_immune_system | 1.13822519 |
80 | MP0005387_immune_system_phenotype | 1.13822519 |
81 | * MP0002420_abnormal_adaptive_immunity | 1.13032413 |
82 | * MP0002429_abnormal_blood_cell | 1.12863043 |
83 | MP0002019_abnormal_tumor_incidence | 1.12634015 |
84 | MP0001986_abnormal_taste_sensitivity | 1.12503753 |
85 | MP0002638_abnormal_pupillary_reflex | 1.12472009 |
86 | MP0003787_abnormal_imprinting | 1.12383565 |
87 | * MP0001819_abnormal_immune_cell | 1.10749426 |
88 | MP0002653_abnormal_ependyma_morphology | 1.10293059 |
89 | MP0003984_embryonic_growth_retardation | 1.08974002 |
90 | MP0002088_abnormal_embryonic_growth/wei | 1.06056654 |
91 | MP0002396_abnormal_hematopoietic_system | 1.06054082 |
92 | MP0010307_abnormal_tumor_latency | 1.04341002 |
93 | MP0005000_abnormal_immune_tolerance | 1.03986506 |
94 | MP0005220_abnormal_exocrine_pancreas | 1.03918659 |
95 | MP0005379_endocrine/exocrine_gland_phen | 1.03889816 |
96 | MP0008961_abnormal_basal_metabolism | 1.03631515 |
97 | MP0009278_abnormal_bone_marrow | 1.03115428 |
98 | MP0009764_decreased_sensitivity_to | 1.00655457 |
99 | MP0004264_abnormal_extraembryonic_tissu | 0.99059271 |
100 | MP0004808_abnormal_hematopoietic_stem | 0.95802118 |
101 | MP0001835_abnormal_antigen_presentation | 0.95513366 |
102 | MP0005075_abnormal_melanosome_morpholog | 0.94665044 |
103 | MP0002452_abnormal_antigen_presenting | 0.94613324 |
104 | MP0000358_abnormal_cell_content/ | 0.92826361 |
105 | MP0000490_abnormal_crypts_of | 0.91720820 |
106 | MP0005394_taste/olfaction_phenotype | 0.90562850 |
107 | MP0005499_abnormal_olfactory_system | 0.90562850 |
108 | MP0002405_respiratory_system_inflammati | 0.89041594 |
109 | MP0002086_abnormal_extraembryonic_tissu | 0.87630576 |
110 | MP0001348_abnormal_lacrimal_gland | 0.85134698 |
111 | MP0009763_increased_sensitivity_to | 0.84780727 |
112 | MP0002160_abnormal_reproductive_system | 0.84108515 |
113 | MP0004381_abnormal_hair_follicle | 0.83721716 |
114 | MP0002277_abnormal_respiratory_mucosa | 0.82996114 |
115 | MP0004197_abnormal_fetal_growth/weight/ | 0.82856616 |
116 | MP0001919_abnormal_reproductive_system | 0.81005887 |
117 | MP0005451_abnormal_body_composition | 0.80669467 |
118 | MP0004233_abnormal_muscle_weight | 0.80302775 |
119 | MP0003656_abnormal_erythrocyte_physiolo | 0.79582452 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.79238497 |
121 | MP0001293_anophthalmia | 0.79167591 |
122 | MP0008789_abnormal_olfactory_epithelium | 0.78275412 |
123 | MP0002998_abnormal_bone_remodeling | 0.76032790 |
124 | MP0004270_analgesia | 0.75349635 |
125 | MP0003786_premature_aging | 0.74686415 |
126 | MP0001851_eye_inflammation | 0.72949538 |
127 | MP0005310_abnormal_salivary_gland | 0.72678250 |
128 | MP0000858_altered_metastatic_potential | 0.72605894 |
129 | MP0008995_early_reproductive_senescence | 0.72274107 |
130 | MP0009703_decreased_birth_body | 0.71776861 |
131 | MP0001663_abnormal_digestive_system | 0.71713992 |
132 | MP0003448_altered_tumor_morphology | 0.71386732 |
133 | MP0005076_abnormal_cell_differentiation | 0.66620860 |
134 | MP0002132_abnormal_respiratory_system | 0.65472834 |
135 | MP0005397_hematopoietic_system_phenotyp | 0.65461028 |
136 | MP0001545_abnormal_hematopoietic_system | 0.65461028 |
137 | MP0005384_cellular_phenotype | 0.63976320 |
138 | MP0008260_abnormal_autophagy | 0.63574227 |
139 | MP0010234_abnormal_vibrissa_follicle | 0.63137532 |
140 | MP0002078_abnormal_glucose_homeostasis | 0.60995015 |
141 | MP0005389_reproductive_system_phenotype | 0.60977480 |
142 | MP0003959_abnormal_lean_body | 0.60528627 |
143 | MP0002938_white_spotting | 0.59638241 |
144 | MP0003172_abnormal_lysosome_physiology | 0.56940384 |
145 | MP0006035_abnormal_mitochondrial_morpho | 0.53646825 |
146 | MP0003045_fibrosis | 0.53577683 |
147 | MP0000609_abnormal_liver_physiology | 0.52092512 |
148 | MP0003806_abnormal_nucleotide_metabolis | 0.51810570 |
149 | MP0000372_irregular_coat_pigmentation | 0.51396534 |
150 | MP0005390_skeleton_phenotype | 0.48582296 |
151 | MP0002136_abnormal_kidney_physiology | 0.46300051 |
152 | MP0003795_abnormal_bone_structure | 0.46045464 |
153 | MP0008873_increased_physiological_sensi | 0.45142847 |
Rank | Gene Set | Z-score |
---|---|---|
1 | T lymphocytopenia (HP:0005403) | 4.54666237 |
2 | Meningitis (HP:0001287) | 4.30597859 |
3 | Gastrointestinal stroma tumor (HP:0100723) | 4.28149180 |
4 | Eczematoid dermatitis (HP:0000976) | 4.26989887 |
5 | Agammaglobulinemia (HP:0004432) | 4.25476258 |
6 | Abnormality of T cell number (HP:0011839) | 4.15864642 |
7 | Vasculitis (HP:0002633) | 4.05758504 |
8 | Colon cancer (HP:0003003) | 3.97391037 |
9 | Panhypogammaglobulinemia (HP:0003139) | 3.95346554 |
10 | Recurrent fungal infections (HP:0002841) | 3.89085073 |
11 | Myositis (HP:0100614) | 3.88840769 |
12 | Increased IgM level (HP:0003496) | 3.85130312 |
13 | Recurrent viral infections (HP:0004429) | 3.83592793 |
14 | Stomatitis (HP:0010280) | 3.82242370 |
15 | Retrobulbar optic neuritis (HP:0100654) | 3.82035752 |
16 | Optic neuritis (HP:0100653) | 3.82035752 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 3.76952625 |
18 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74174215 |
19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74174215 |
20 | IgA deficiency (HP:0002720) | 3.68453172 |
21 | Autoimmune hemolytic anemia (HP:0001890) | 3.62253085 |
22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.58592791 |
23 | Encephalitis (HP:0002383) | 3.56876986 |
24 | Birth length less than 3rd percentile (HP:0003561) | 3.52853473 |
25 | Orchitis (HP:0100796) | 3.51380267 |
26 | Recurrent sinusitis (HP:0011108) | 3.43295404 |
27 | Recurrent bacterial skin infections (HP:0005406) | 3.39635025 |
28 | Chronic bronchitis (HP:0004469) | 3.38515662 |
29 | Abnormality of T cells (HP:0002843) | 3.33583005 |
30 | Pulmonary infiltrates (HP:0002113) | 3.32786630 |
31 | Chronic diarrhea (HP:0002028) | 3.30162445 |
32 | Reticulocytopenia (HP:0001896) | 3.28741021 |
33 | Abnormality of macrophages (HP:0004311) | 3.26421917 |
34 | Obstructive lung disease (HP:0006536) | 3.25249531 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25249531 |
36 | Late onset (HP:0003584) | 3.24903392 |
37 | Recurrent abscess formation (HP:0002722) | 3.24803853 |
38 | Combined immunodeficiency (HP:0005387) | 3.20187992 |
39 | Pustule (HP:0200039) | 3.17845492 |
40 | Abnormality of eosinophils (HP:0001879) | 3.10718718 |
41 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.08296603 |
42 | Cellular immunodeficiency (HP:0005374) | 3.07483350 |
43 | Granulocytopenia (HP:0001913) | 3.03894333 |
44 | IgM deficiency (HP:0002850) | 3.03148085 |
45 | Gastrointestinal infarctions (HP:0005244) | 2.98834941 |
46 | Leukocytosis (HP:0001974) | 2.94630477 |
47 | Ependymoma (HP:0002888) | 2.94515131 |
48 | Recurrent skin infections (HP:0001581) | 2.93250691 |
49 | Abnormality of the prostate (HP:0008775) | 2.93214929 |
50 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.91809252 |
51 | Bronchitis (HP:0012387) | 2.90948166 |
52 | Urticaria (HP:0001025) | 2.86909485 |
53 | Inflammation of the large intestine (HP:0002037) | 2.84211129 |
54 | Prominent metopic ridge (HP:0005487) | 2.81689958 |
55 | Increased IgE level (HP:0003212) | 2.80018670 |
56 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.79049103 |
57 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.79049103 |
58 | Eosinophilia (HP:0001880) | 2.78943126 |
59 | Colitis (HP:0002583) | 2.76764708 |
60 | Keratoconjunctivitis sicca (HP:0001097) | 2.74643034 |
61 | Asplenia (HP:0001746) | 2.74457641 |
62 | Premature loss of primary teeth (HP:0006323) | 2.72370720 |
63 | Abnormal number of erythroid precursors (HP:0012131) | 2.70647241 |
64 | Basal cell carcinoma (HP:0002671) | 2.67505113 |
65 | Premature graying of hair (HP:0002216) | 2.67310275 |
66 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.64783489 |
67 | Keratoconjunctivitis (HP:0001096) | 2.64278866 |
68 | Abnormality of the anterior horn cell (HP:0006802) | 2.64011827 |
69 | Degeneration of anterior horn cells (HP:0002398) | 2.64011827 |
70 | Orthostatic hypotension (HP:0001278) | 2.63266530 |
71 | Verrucae (HP:0200043) | 2.62310378 |
72 | Papilloma (HP:0012740) | 2.62310378 |
73 | 11 pairs of ribs (HP:0000878) | 2.61155164 |
74 | Recurrent bronchitis (HP:0002837) | 2.59236503 |
75 | Carpal bone hypoplasia (HP:0001498) | 2.57285212 |
76 | Intestinal atresia (HP:0011100) | 2.56252254 |
77 | Hemoptysis (HP:0002105) | 2.54741403 |
78 | Overlapping toe (HP:0001845) | 2.47810378 |
79 | Supernumerary spleens (HP:0009799) | 2.47660243 |
80 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.47534338 |
81 | Cellulitis (HP:0100658) | 2.46666598 |
82 | Missing ribs (HP:0000921) | 2.45364347 |
83 | Macrocytic anemia (HP:0001972) | 2.45308420 |
84 | Medulloblastoma (HP:0002885) | 2.43499455 |
85 | Chest pain (HP:0100749) | 2.42816276 |
86 | Stomach cancer (HP:0012126) | 2.42719462 |
87 | Skin rash (HP:0000988) | 2.42160603 |
88 | Abnormality of the metopic suture (HP:0005556) | 2.37751474 |
89 | Absent thumb (HP:0009777) | 2.37747051 |
90 | Aplastic anemia (HP:0001915) | 2.37477247 |
91 | Osteomyelitis (HP:0002754) | 2.37391806 |
92 | Autoimmune thrombocytopenia (HP:0001973) | 2.37094629 |
93 | Pallor (HP:0000980) | 2.29182689 |
94 | Lymphoma (HP:0002665) | 2.28928821 |
95 | Emphysema (HP:0002097) | 2.28291499 |
96 | Hypergammaglobulinemia (HP:0010702) | 2.28101062 |
97 | Optic nerve coloboma (HP:0000588) | 2.28099672 |
98 | Restrictive lung disease (HP:0002091) | 2.27394442 |
99 | Abnormality of the pleura (HP:0002103) | 2.24876534 |
100 | Oral leukoplakia (HP:0002745) | 2.24395508 |
101 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.24164520 |
102 | Prostate neoplasm (HP:0100787) | 2.22452143 |
103 | Cerebral hypomyelination (HP:0006808) | 2.20565519 |
104 | Dysautonomia (HP:0002459) | 2.19542254 |
105 | Hypochromic anemia (HP:0001931) | 2.19120368 |
106 | Hypertensive crisis (HP:0100735) | 2.17666931 |
107 | Bronchiectasis (HP:0002110) | 2.16852965 |
108 | Arterial thrombosis (HP:0004420) | 2.16468320 |
109 | Acute hepatic failure (HP:0006554) | 2.16287494 |
110 | Gangrene (HP:0100758) | 2.15826456 |
111 | Anorexia (HP:0002039) | 2.15712184 |
112 | Agnosia (HP:0010524) | 2.15098069 |
113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14026877 |
114 | Lymphopenia (HP:0001888) | 2.12339753 |
115 | Abnormal number of incisors (HP:0011064) | 2.10267289 |
116 | Neoplasm of the pancreas (HP:0002894) | 2.08981503 |
117 | Recurrent lower respiratory tract infections (HP:0002783) | 2.08158810 |
118 | Pulmonary fibrosis (HP:0002206) | 2.08015046 |
119 | Joint swelling (HP:0001386) | 2.07741735 |
120 | Neutropenia (HP:0001875) | 2.07605969 |
121 | Abnormality of abdominal situs (HP:0011620) | 2.07108636 |
122 | Abdominal situs inversus (HP:0003363) | 2.07108636 |
123 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.06626132 |
124 | Thyroiditis (HP:0100646) | 2.05470847 |
125 | Recurrent pneumonia (HP:0006532) | 2.05296996 |
126 | Deep palmar crease (HP:0006191) | 2.03970100 |
127 | Pulmonary embolism (HP:0002204) | 2.03730126 |
128 | Abnormality of T cell physiology (HP:0011840) | 2.03668496 |
129 | Sepsis (HP:0100806) | 2.03064544 |
130 | Abnormality of male internal genitalia (HP:0000022) | 2.01570216 |
131 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.99287367 |
132 | Microvesicular hepatic steatosis (HP:0001414) | 1.99259118 |
133 | Rough bone trabeculation (HP:0100670) | 1.99144796 |
134 | Leukopenia (HP:0001882) | 1.98743206 |
135 | Hypoglycemic seizures (HP:0002173) | 1.97267163 |
136 | Spontaneous hematomas (HP:0007420) | 1.96759903 |
137 | Cleft eyelid (HP:0000625) | 1.95890130 |
138 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.94015865 |
139 | Protruding tongue (HP:0010808) | 1.93962139 |
140 | Selective tooth agenesis (HP:0001592) | 1.93908409 |
141 | Abnormality of B cell number (HP:0010975) | 1.91316488 |
142 | B lymphocytopenia (HP:0010976) | 1.91316488 |
143 | Chronic sinusitis (HP:0011109) | 1.91008571 |
144 | Petechiae (HP:0000967) | 1.90196061 |
145 | Hypoplasia of the thymus (HP:0000778) | 1.89368232 |
146 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.86680497 |
147 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.86194627 |
148 | IgG deficiency (HP:0004315) | 1.85969069 |
149 | Trismus (HP:0000211) | 1.85682762 |
150 | Recurrent otitis media (HP:0000403) | 1.85293518 |
151 | Long palpebral fissure (HP:0000637) | 1.85288017 |
152 | Microretrognathia (HP:0000308) | 1.83947743 |
153 | Unsteady gait (HP:0002317) | 1.83896133 |
154 | Long eyelashes (HP:0000527) | 1.83465546 |
155 | Amaurosis fugax (HP:0100576) | 1.82774501 |
156 | Chronic otitis media (HP:0000389) | 1.82120583 |
157 | Rib fusion (HP:0000902) | 1.79465420 |
158 | Gastrointestinal inflammation (HP:0004386) | 1.78417130 |
159 | Anal stenosis (HP:0002025) | 1.76221066 |
160 | Emotional lability (HP:0000712) | 1.76007674 |
161 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.74927643 |
162 | Limb hypertonia (HP:0002509) | 1.74421888 |
163 | Severe combined immunodeficiency (HP:0004430) | 1.72502829 |
164 | Symptomatic seizures (HP:0011145) | 1.72412432 |
165 | Rhabdomyosarcoma (HP:0002859) | 1.72204204 |
166 | Menstrual irregularities (HP:0000858) | 1.71455758 |
167 | Patellar aplasia (HP:0006443) | 1.70097746 |
168 | Abnormality of the labia minora (HP:0012880) | 1.68638299 |
169 | Progressive muscle weakness (HP:0003323) | 1.68569338 |
170 | Acute lymphatic leukemia (HP:0006721) | 1.68423420 |
171 | Nasal polyposis (HP:0100582) | 1.68344720 |
172 | Intestinal fistula (HP:0100819) | 1.67057264 |
173 | Neoplasm of the oral cavity (HP:0100649) | 1.65952725 |
174 | Impaired smooth pursuit (HP:0007772) | 1.65782503 |
175 | Horseshoe kidney (HP:0000085) | 1.65679529 |
176 | Pelvic girdle muscle weakness (HP:0003749) | 1.65494998 |
177 | Thrombocytosis (HP:0001894) | 1.65118459 |
178 | Myelodysplasia (HP:0002863) | 1.65108325 |
179 | Poikiloderma (HP:0001029) | 1.63449405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK3 | 4.45096164 |
2 | BUB1 | 3.67715993 |
3 | PASK | 3.26632570 |
4 | MAP4K1 | 3.26511027 |
5 | TAOK3 | 3.24856825 |
6 | CDC7 | 3.19765826 |
7 | RIPK4 | 3.15123729 |
8 | MAPK15 | 2.94870142 |
9 | TSSK6 | 2.89181810 |
10 | MAP3K14 | 2.72907122 |
11 | IKBKE | 2.64382325 |
12 | PRPF4B | 2.64349925 |
13 | EIF2AK1 | 2.37106244 |
14 | GRK6 | 2.20934051 |
15 | FES | 2.16186452 |
16 | IRAK4 | 2.14781220 |
17 | TBK1 | 2.10301602 |
18 | TESK2 | 1.97416004 |
19 | WEE1 | 1.97158397 |
20 | SCYL2 | 1.91345374 |
21 | IKBKB | 1.86698193 |
22 | HIPK2 | 1.86288643 |
23 | EIF2AK3 | 1.81419136 |
24 | TXK | 1.76478632 |
25 | MAP3K9 | 1.73864487 |
26 | STK16 | 1.72495906 |
27 | JAK1 | 1.67213804 |
28 | MAP3K10 | 1.59303108 |
29 | ALK | 1.56859625 |
30 | DAPK1 | 1.53560493 |
31 | PNCK | 1.51329449 |
32 | FGFR4 | 1.50447302 |
33 | NLK | 1.48728680 |
34 | ITK | 1.43127728 |
35 | CSK | 1.39892297 |
36 | UHMK1 | 1.36334783 |
37 | MAP3K11 | 1.34074459 |
38 | BTK | 1.32356167 |
39 | SMG1 | 1.32086113 |
40 | BRD4 | 1.31565645 |
41 | SRPK1 | 1.31485773 |
42 | FLT3 | 1.30313627 |
43 | MST4 | 1.28295492 |
44 | CDK12 | 1.26160651 |
45 | HCK | 1.24334852 |
46 | EEF2K | 1.23250661 |
47 | NEK2 | 1.21886086 |
48 | KIT | 1.21249466 |
49 | MAP2K2 | 1.20816418 |
50 | MATK | 1.20155347 |
51 | CDK7 | 1.20057582 |
52 | MARK3 | 1.18198516 |
53 | JAK3 | 1.17344603 |
54 | BMPR2 | 1.15087349 |
55 | DYRK3 | 1.15029727 |
56 | KSR2 | 1.13705434 |
57 | STK10 | 1.12406953 |
58 | ADRBK2 | 1.11889369 |
59 | ZAP70 | 1.11597669 |
60 | MAP3K13 | 1.08886212 |
61 | RPS6KA4 | 1.07164270 |
62 | BCKDK | 1.06413251 |
63 | ATR | 1.04764052 |
64 | VRK1 | 1.02908204 |
65 | CSF1R | 1.02858831 |
66 | PRKCQ | 1.00990474 |
67 | PLK1 | 0.99201326 |
68 | PAK4 | 0.96789610 |
69 | CHEK1 | 0.96727023 |
70 | JAK2 | 0.96448981 |
71 | CDK4 | 0.91737544 |
72 | NME1 | 0.91274327 |
73 | PLK3 | 0.90430285 |
74 | MAP3K8 | 0.89790251 |
75 | MAP3K2 | 0.89165115 |
76 | TGFBR1 | 0.88101211 |
77 | ZAK | 0.81794216 |
78 | PLK4 | 0.81423702 |
79 | BRAF | 0.79629646 |
80 | TEC | 0.79119566 |
81 | SYK | 0.77637052 |
82 | VRK2 | 0.77386127 |
83 | CDK19 | 0.77303744 |
84 | AURKB | 0.77111172 |
85 | KDR | 0.76626581 |
86 | ARAF | 0.74095061 |
87 | FGFR3 | 0.73659697 |
88 | CDK2 | 0.73338303 |
89 | AURKA | 0.72472160 |
90 | CSNK2A2 | 0.70837805 |
91 | TAOK2 | 0.68980916 |
92 | RAF1 | 0.68631466 |
93 | MAPK11 | 0.68433850 |
94 | CHUK | 0.66311134 |
95 | EPHB1 | 0.65527785 |
96 | BRSK1 | 0.65250191 |
97 | MAPK7 | 0.62594318 |
98 | EPHA3 | 0.62003695 |
99 | FGFR1 | 0.61588797 |
100 | CHEK2 | 0.60383299 |
101 | MKNK1 | 0.58779596 |
102 | MAP3K12 | 0.58411795 |
103 | PIM1 | 0.58346414 |
104 | NME2 | 0.57909177 |
105 | ATM | 0.57394515 |
106 | RPS6KB2 | 0.56875588 |
107 | LCK | 0.56064259 |
108 | NUAK1 | 0.56026349 |
109 | PRKCI | 0.54136832 |
110 | MAP3K1 | 0.53365697 |
111 | FGR | 0.53049895 |
112 | LRRK2 | 0.50546884 |
113 | TYK2 | 0.50463422 |
114 | IRAK1 | 0.50115115 |
115 | IRAK3 | 0.47963285 |
116 | CSNK1E | 0.47863184 |
117 | RPS6KA5 | 0.47318052 |
118 | STK4 | 0.46434919 |
119 | PDK1 | 0.46393215 |
120 | ERN1 | 0.46207117 |
121 | ACVR1B | 0.45307471 |
122 | MAPK12 | 0.44458443 |
123 | TLK1 | 0.44147201 |
124 | MAPKAPK2 | 0.43925326 |
125 | LYN | 0.42175078 |
126 | PRKD2 | 0.42170622 |
127 | CLK1 | 0.42159864 |
128 | CSNK2A1 | 0.41300505 |
129 | BRSK2 | 0.40454095 |
130 | PTK2 | 0.40306471 |
131 | EIF2AK2 | 0.39209324 |
132 | SIK3 | 0.39119514 |
133 | SIK2 | 0.37692863 |
134 | NTRK3 | 0.37023854 |
135 | MAP2K3 | 0.36251650 |
136 | MAP2K6 | 0.35829596 |
137 | CDK1 | 0.35480304 |
138 | TAF1 | 0.35427854 |
139 | TNK2 | 0.35068484 |
140 | WNK4 | 0.34055885 |
141 | BLK | 0.33994875 |
142 | PRKDC | 0.33640297 |
143 | MTOR | 0.33599378 |
144 | CDK8 | 0.32990443 |
145 | MAPK3 | 0.30234357 |
146 | FYN | 0.28365405 |
147 | PRKCD | 0.26420698 |
148 | PRKCH | 0.24465749 |
149 | MAPK4 | 0.21249501 |
150 | RPS6KA1 | 0.20393174 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 3.68888094 |
2 | Spliceosome_Homo sapiens_hsa03040 | 3.38274517 |
3 | DNA replication_Homo sapiens_hsa03030 | 3.34861471 |
4 | Mismatch repair_Homo sapiens_hsa03430 | 3.34622608 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 3.25593943 |
6 | Proteasome_Homo sapiens_hsa03050 | 3.12542551 |
7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.07256918 |
8 | RNA transport_Homo sapiens_hsa03013 | 2.75858223 |
9 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.65444160 |
10 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.65396333 |
11 | Protein export_Homo sapiens_hsa03060 | 2.57807966 |
12 | Base excision repair_Homo sapiens_hsa03410 | 2.21543286 |
13 | Leishmaniasis_Homo sapiens_hsa05140 | 2.17043747 |
14 | RNA degradation_Homo sapiens_hsa03018 | 2.09972172 |
15 | Viral myocarditis_Homo sapiens_hsa05416 | 2.09531389 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.05471219 |
17 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.03789480 |
18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.90161453 |
19 | Homologous recombination_Homo sapiens_hsa03440 | 1.80925357 |
20 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.78758649 |
21 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.77779171 |
22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.73686014 |
23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.62119986 |
24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58210609 |
25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57304226 |
26 | Cell cycle_Homo sapiens_hsa04110 | 1.54448995 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.48824328 |
28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46177522 |
29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40518461 |
30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.34595838 |
31 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32786914 |
32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.26678827 |
33 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.26237727 |
34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16811691 |
35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.16338131 |
36 | Allograft rejection_Homo sapiens_hsa05330 | 1.12384365 |
37 | Tuberculosis_Homo sapiens_hsa05152 | 1.12202759 |
38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10112286 |
39 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09159826 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.08671019 |
41 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07437874 |
42 | Purine metabolism_Homo sapiens_hsa00230 | 1.06351067 |
43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.01291859 |
44 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.96446234 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.95267899 |
46 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.93811160 |
47 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93406527 |
48 | Insulin secretion_Homo sapiens_hsa04911 | 0.91558213 |
49 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90578149 |
50 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87735422 |
51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.85760594 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.85654539 |
53 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84706597 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.84216474 |
55 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82520918 |
56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82254553 |
57 | Hepatitis C_Homo sapiens_hsa05160 | 0.80581078 |
58 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.79833796 |
59 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77743312 |
60 | Malaria_Homo sapiens_hsa05144 | 0.76847134 |
61 | Asthma_Homo sapiens_hsa05310 | 0.76371303 |
62 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74490342 |
63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71257596 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68881641 |
65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68657180 |
66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68458928 |
67 | Long-term potentiation_Homo sapiens_hsa04720 | 0.66978726 |
68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65792300 |
69 | Measles_Homo sapiens_hsa05162 | 0.65157902 |
70 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.64988298 |
71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.61504989 |
72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.59800726 |
73 | Legionellosis_Homo sapiens_hsa05134 | 0.59138381 |
74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57110362 |
75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56880418 |
76 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56781515 |
77 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.56557983 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55666357 |
79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.55643214 |
80 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54796205 |
81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54058776 |
82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.53717056 |
83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.52447967 |
84 | Shigellosis_Homo sapiens_hsa05131 | 0.50547374 |
85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.48564167 |
86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.45245556 |
87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.43780280 |
88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.43587050 |
89 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.42619107 |
90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.41845373 |
91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41329329 |
92 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.40298139 |
93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40235878 |
94 | Apoptosis_Homo sapiens_hsa04210 | 0.39476995 |
95 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38331155 |
96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38326489 |
97 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37358177 |
98 | Hepatitis B_Homo sapiens_hsa05161 | 0.37020497 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36559312 |
100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36519381 |
101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35827176 |
102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34947845 |
103 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.34402850 |
104 | Alcoholism_Homo sapiens_hsa05034 | 0.34335825 |
105 | Pertussis_Homo sapiens_hsa05133 | 0.33505779 |
106 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.33315639 |
107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33292606 |
108 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33121397 |
109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31508437 |
110 | Circadian rhythm_Homo sapiens_hsa04710 | 0.31274033 |
111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.29997827 |
112 | Prion diseases_Homo sapiens_hsa05020 | 0.29773127 |
113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29404789 |
114 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28867142 |
115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.28841729 |
116 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28603813 |
117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.28316521 |
118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26443122 |
119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25705559 |
120 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.24154601 |
121 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.23111149 |
122 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.22314587 |
123 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.21926524 |
124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.21542749 |
125 | Phagosome_Homo sapiens_hsa04145 | 0.21231736 |
126 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.20123022 |
127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.16785201 |
128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16696054 |
129 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.16424621 |
130 | Melanogenesis_Homo sapiens_hsa04916 | 0.15952976 |
131 | Platelet activation_Homo sapiens_hsa04611 | 0.15828401 |
132 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15345351 |
133 | Salmonella infection_Homo sapiens_hsa05132 | 0.13357869 |
134 | Prostate cancer_Homo sapiens_hsa05215 | 0.12973612 |
135 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.11490465 |
136 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.10051934 |
137 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.09801669 |
138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.09232019 |
139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.08816974 |
140 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.08083179 |